Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study
Clinical trial NCT05457829 · RECRUITING
Trial details
- NCT number
- NCT05457829
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-30
- Primary completion
- 2026-06-30
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.